Intranasal oxytocin (IN OXT) has been proposed as a treatment for autism spectrum disorder
(ASD); however, little is known about the effects of long-term exposure. This is the first study …

Intranasal oxytocin (IN OXT) administration has been proposed as a pharmacological
treatment for a range of biomedical conditions including neurodevelopmental disorders …

Oxytocin (OT) is a neuropeptide involved in mammalian social behavior. It is currently in
clinical trials for the treatment of autism spectrum disorder (ASD). Previous studies in healthy …

Intranasal (IN) administration is a widely used method for examining the effect of oxytocin
(OT) on social behavior and cognition in healthy subjects and psychiatric populations. IN-OT …

Oxytocin has been suggested as a treatment to promote positive social interactions in
people with Autism Spectrum Disorders (ASD). However, it is difficult to test this effect …

Studies in a variety of species have reported enhanced prosocial effects after an acute
administration of the neuromodulating hormone, oxytocin (OT). Although the exact …

Background There are no effective medications for the treatment of social cognition/function
deficits in autism spectrum disorder (ASD), and adult intervention literature in this area is …

Autism spectrum disorder (ASD) is characterized by core social deficits. Prognosis is poor, in
part, because existing medications target only associated ASD features. Emerging evidence …

Intranasal oxytocin (IN-OT) modulates social perception and cognition in humans and could
be an effective pharmacotherapy for treating social impairments associated with …

Background There is a paucity of treatments targeting core symptom domains in Autism
Spectrum Disorder (ASD). Several animal models and research in typically developing …